The companies Vaxcyte, Generate Biomedicines, and Immunic bagged the biggest biotech funding rounds overall in February 2026.

February 2026 saw a major biopharma acquisition, four key buyouts, and licensing deals in antibodies, small molecules, and ...

Delve into the field of pulmonary hypertension as GSK places a $950M bet on 35Pharma's candidate HS235 following the footsteps of Winrevair.

Join industry and academic leaders in Cambridge for Champions Oncology’s UK Symposium, a one‑day, in‑person event focused on emerging translational oncology strategies. Hear expert perspectives on ...

Rare Disease Day is held on the last day of February to raise awareness for rare diseases and address drug development ...

New treatments for male infertility could widen therapeutic options and possibly shift the treatment burden from women.

Explore Pfizer’s evolving pipeline strategy, expanding into oncology and obesity to drive growth beyond its COVID-19 success.

Discover six RNAi biotech companies helping to drive momentum in a field that can precisely target disease at its genetic root.